Blocked Tubes on an HSG: Proximal vs Distal

Two HSGs, two reports of blocked tubes, and still no clear answer about what happens next — that is a specific kind of stuck. It is not the same as one ambiguous scan, and it is not the same as a clean diagnosis either, because "blocked" on an HSG can mean a plumbing problem that needs surgery or a test artifact that meant nothing at all. Before agreeing to a third imaging test, or booking an IUI or IVF cycle on the strength of two reports, it is worth knowing that the location of the blockage on the film changes how much those two results should be trusted.

Two HSGs both said blocked tubes — is a third test worth it?

A third test can be worth it, but only if it uses a different technique than the first two, and only after you know where on the tube each report placed the blockage. A Femvue- or HyCoSy-style saline-air sonogram is a genuinely different modality from x-ray HSG, so it can add real information rather than repeat the same false signal — especially if both prior reports called the blockage proximal, which is the location the test gets wrong most often.

What's the difference between proximal and distal tubal blockage on an HSG?

Proximal blockage sits at the cornual end, where the fallopian tube meets the uterus — the first inch or so the dye has to pass through. Distal blockage sits at the far end, near the fimbriae and ampulla, the part of the tube nearest the ovary. The two locations are read the same way on an HSG report — "tube not filled beyond X point" — but they come from very different biology, and they carry very different odds of being real. A radiology report that simply says "bilateral tubal occlusion" without stating where is missing the single most useful piece of information in the study.

Could the blockage be a false positive from spasm or debris rather than real disease?

Yes, and only one end of the tube fails this way often enough to matter. The uterotubal junction near the cornu is narrow and muscular, and it can clamp shut in response to the catheter, the injected fluid, or simple anxiety during the procedure — a transient spasm that has nothing to do with the tube's actual anatomy. The fimbrial and ampullary end has no comparable muscular sphincter to spasm; when dye does not reach past it, the more common explanations are adhesions, prior infection, or a dilated, fluid-filled segment (a hydrosalpinx) that is genuinely closed off. This is why radiologists and reproductive endocrinologists treat a report of bilateral proximal occlusion with more skepticism than a report of bilateral distal occlusion, even though both sentences read identically on the page, and why a single HSG finding of proximal occlusion is generally treated as provisional rather than diagnostic. The classic meta-analysis of HSG against laparoscopy with chromopertubation — the accepted reference standard, since a surgeon can see and probe the tube directly — pooled 20 studies and 4,179 patients and found HSG sensitivity around 0.65 and specificity around 0.83 for tubal patency, meaning both false-negative and false-positive results happen at a meaningful rate. A 2023 prospective comparison of HSG against laparoscopy in 105 infertility patients found the same pattern: agreement between the two tests was good but incomplete, and discordant results clustered at the proximal end. The American Society for Reproductive Medicine's 2015 committee opinion on evaluating the infertile female is explicit that HSG is a screening test, and that unexpected or bilateral proximal occlusion warrants confirmation before it is treated as a final answer. Two HSGs agreeing on proximal blockage is more convincing than one, but it is still two readings of the same test type, not two independent lines of evidence — a point that gets lost when a patient is told "we've confirmed it twice."

What is selective salpingography with tubal cannulation, and why didn't anyone mention it?

It is a procedure, usually done by an interventional radiologist or a reproductive endocrinologist with fluoroscopic or hysteroscopic guidance, in which a thin catheter is threaded through the cervix and uterus directly into the tubal opening to inject contrast right at the site of a suspected proximal blockage. Because the catheter bypasses the uterotubal junction that may simply be in spasm, it distinguishes a genuine occlusion from a false positive in the same sitting — and if the obstruction turns out to be a plug of mucus or debris rather than scar tissue, the same catheter can often clear it, sometimes restoring flow through the tube during the same procedure. A retrospective review of 160 couples who underwent fluoroscopy-guided fallopian tube recanalization found that a meaningful share of tubes read as proximally blocked on HSG were successfully reopened this way. It is not offered everywhere, and it does not work for every case — dense scar tissue and long-segment disease do not resolve with a catheter — but it is a reasonable, specific question to bring to a reproductive endocrinologist or interventional radiologist before assuming that "proximal blockage" means the tube is permanently unusable.

Is a Femvue or HyCoSy saline-air sonogram actually new information, or just another version of the same test?

It depends on what changes between tests. HSG uses x-ray and iodinated contrast; HyCoSy and Femvue-style tests use ultrasound with a saline-air or foam contrast agent, so the imaging physics and the person's experience of the procedure are genuinely different, and a spasm triggered by one modality does not automatically repeat with the other. Some radiology literature places HyCoSy-type testing close to HSG in overall accuracy against laparoscopy, so it should not be over-sold as more definitive — but a different modality, done by a different practitioner, on a different day, is a real second opinion rather than the same test result repackaged. Where a third test earns its cost is precisely the proximal-occlusion scenario your OB is describing: a new technique has a real chance of turning up a different answer, whereas a third x-ray HSG mostly just repeats whatever produced the spasm the first two times.

If a tube is really blocked at the distal end, does that mean a hydrosalpinx — and does that change the plan?

Often, yes, and a hydrosalpinx is the one tubal finding that changes the treatment plan rather than just adjusting the odds. Distal blockage traps and dilates the tube with fluid, and that fluid is not inert: it can leak backward into the uterine cavity around the time of embryo transfer and interfere with implantation. A Cochrane review of surgical treatment for tubal disease before IVF found that removing or otherwise addressing a hydrosalpinx before treatment improved outcomes compared with proceeding to IVF with the hydrosalpinx left in place. That is a decision for a reproductive endocrinologist or gynecologic surgeon, not a self-directed one, but it is the reason a distal finding is worth pursuing to a clear anatomical answer even when the two of you are eager to move straight to treatment.

Does "the tubes are open" actually mean the tubes work?

No — patency and function are not the same thing, and this is the gap most patients are never warned about. Patency means dye or fluid can pass through the tube's lumen. Function means the tube's cilia can beat in coordination to sweep the egg toward the uterus, the smooth muscle can contract in the right pattern, and the fimbriae can actually catch the egg after ovulation. A tube can be fully open and still transport poorly if its lining was damaged by prior chlamydia or another pelvic infection, by endometriosis affecting the tube or surrounding pelvis, or by chronic inflammation — none of which show up as a blockage on any patency test. If there is any history of a sexually transmitted infection, unexplained pelvic pain, or a prior diagnosis of pelvic inflammatory disease, chlamydia antibody serology is worth asking about specifically; a 2023 systematic review and meta-analysis found chlamydia antibodies were associated with a meaningfully higher risk of tubal factor infertility even in women with no memory of a diagnosed infection. "Open" tubes are good news, but they close the door on one explanation, not on all of them — and if every other test comes back clean, it is worth reading our breakdown of the root causes of unexplained infertility that get missed before the file is labeled unexplained.

Should we do IUI, or go straight to IVF, if the tubes turn out open?

That decision belongs with your reproductive endocrinologist, and our IUI and IVF support page is a reasonable starting point for what that conversation covers, but the decision itself depends on more than just patency. IUI only makes sense with at least one tube that is both open and functional, since the sperm and egg still have to meet and travel through it naturally; if the two of you have already had a confirmed proximal false positive resolved, or a genuinely patent tube on the third test, IUI becomes a reasonable next step to discuss. It is also worth asking your RE to put a number on it up front — how many IUI cycles they would recommend trying before moving to IVF, and whether your husband's semen analysis findings change that number. Given his abnormal morphology result, ask specifically whether his sample supports IUI at all, or whether it points toward IVF with ICSI regardless of tubal status; our comparison of what a standard semen analysis can and cannot tell you versus a sperm DNA fragmentation test is a useful companion conversation for him to have with his own provider. IVF bypasses tubal transport altogether, which is why a truly and permanently blocked tube — as opposed to a spasm or a resolved obstruction — tends to point more directly toward it.

What does the tubal-flushing research actually show, and what should I not read into it?

The largest trial in this space is not about diagnosis at all — it is about a possible side effect of the test itself. The Dutch H2Oil trial randomized 1,119 infertile women having an HSG to oil-based or water-based contrast and followed them for ongoing pregnancy within six months without further treatment; the oil-contrast group had a higher rate of ongoing pregnancy (39.7% versus 29.1%) and live birth (38.8% versus 28.1%) than the water-contrast group. That is a real, well-designed finding, but it describes a population-level effect of the contrast used during a diagnostic test — a possible mild flushing or lubricating effect on open tubes — not a treatment, and not a promise for any individual. It says nothing about proximal versus distal disease, nothing about hydrosalpinx, and nothing about what happens for tubes that are truly, structurally blocked. If your OB brings up "flushing" as an option, ask directly whether they mean this specific research on contrast type during HSG, or something else, since the term gets used loosely.

What should I ask for by name at my next appointment?

Ask for the original HSG or Femvue images and reports, not just the summary line, and ask your OB or RE to state explicitly whether each blockage was called proximal or distal and on what basis. Ask whether selective salpingography with tubal cannulation is available locally or through a referral, since it can confirm and sometimes treat proximal occlusion in one visit. Ask whether a hydrosalpinx was ever identified or ruled out on ultrasound, since that finding changes the IVF conversation. Ask about chlamydia antibody testing if there is any relevant history, and ask your RE to name a specific IUI-versus-IVF plan, including cycle count, rather than leaving it open-ended. Our list of questions worth bringing to a fertility specialist appointment has a longer version of this list for the rest of the workup.

Where does a metabolic and immune-focused evaluation fit around a tubal-factor diagnosis?

It fits around the reproductive endocrinologist's structural workup, not in place of it. A tube that is confirmed open and functional still sits inside a body where inflammation, blood flow, thyroid and metabolic health, and immune signaling affect implantation and egg quality — the same factors that matter for anyone going through IUI or IVF, tubal factor or not. At East to West Fertility, that side of the picture is organized into a Personalized 90-Day Fertility Roadmap built from a Metabolic & Immune Fertility Evaluation, using the same three areas we track for every patient: Blood Flow & Signaling, Egg & Sperm Quality, and Fertility Environment — what we call the 3 Fertility Dials. That evaluation does not diagnose or treat tubal disease; it works alongside whatever your OB and RE decide about the tubes themselves, and it is a sensible parallel track for couples across Long Island who are also managing male-factor findings like an abnormal morphology result — our male-factor evaluation covers that side in more depth. Many patients we see, both in Huntington and further out on Long Island, describe exactly this situation: one confusing structural finding, and no one helping them work the rest of the picture at the same time.

Two HSGs calling the same tubes blocked is real information, but it is not the whole answer until you know where the block was reported and what test produced it. A proximal finding on two x-ray studies deserves a different-modality look or a cannulation referral before it is treated as final; a distal finding, especially with a dilated tube, deserves a clear hydrosalpinx conversation before any IVF transfer. Either way, "the tubes are open" is the start of the next conversation about function, not the end of the one about blockage — and both belong with your reproductive endocrinologist, with the rest of your and your husband's fertility picture running in parallel rather than waiting its turn.

This article is for general educational purposes and is not a substitute for individualized medical care. Testing, diagnosis, imaging interpretation and any treatment or medication decisions belong with your OB-GYN or reproductive endocrinologist, based on your own history.

East to West Fertility is a metabolic and immune-focused fertility clinic in Huntington, Long Island, serving patients across Long Island, NYC, and beyond. Learn more about our Metabolic & Immune Fertility Evaluation or call 631-416-4940.

References:

• Practice Committee of the American Society for Reproductive Medicine. "Diagnostic evaluation of the infertile female: a committee opinion." Fertility and Sterility, 2015;103(6):e44-50.
• Swart P, Mol BW, van der Veen F, van Beurden M, Redekop WK, Bossuyt PM. "The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis." Fertility and Sterility, 1995;64(3):486-491. (20 studies, 4,179 patients, vs. laparoscopy with chromopertubation.)
• Sharma P, Sunita S, Shrivastava N, Bhargava M. "Comparison of Hysterosalpingography and Laparoscopy in the Evaluation of Infertility: A Prospective Study." Journal of Obstetrics and Gynaecology of India, 2023;73(3):262-269. (105 patients.)
• Zafarani F, Ghaffari F, Ahmadi F, Soleimani Mehranjani M, Shahrzad G. "Hysterosalpingography in the assessment of proximal tubal pathology: a review of congenital and acquired abnormalities." The British Journal of Radiology, 2021;94(1122):20201386.
• Wang JW, Rustia GM, Wood-Molo M, Tasse J, Tabriz D, Turba UC, Arslan B, Madassery S. "Conception rates after fluoroscopy-guided fallopian tubal cannulation: an alternative to in vitro fertilization for patients with tubal occlusion." Therapeutic Advances in Reproductive Health, 2020;14:2633494120954248. (160 couples, retrospective single-center review.)
• Melo P, Georgiou EX, Johnson N, van Voorst SF, Strandell A, Mol BWJ, Becker C, Granne IE. "Surgical treatment for tubal disease in women due to undergo in vitro fertilisation." Cochrane Database of Systematic Reviews, 2020;10:CD002125.
• Zuo Y, Jiang TT, Teng Y, Han Y, Yin YP, Chen XS. "Associations of Chlamydia trachomatis serology with fertility-related and pregnancy adverse outcomes in women: a systematic review and meta-analysis of observational studies." EBioMedicine, 2023;94:104696.
• Dreyer K, van Rijswijk J, Mijatovic V, et al. "Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women." The New England Journal of Medicine, 2017;376(21):2043-2052. (Randomized trial, 1,119 women, 27 hospitals.)
• Roy O, Kumari S, Adiga SK, Joshi MB, Kumar A, Venkatraman G, Kannan N, Kalthur G. "Functional Changes in the Fallopian Tube: Environmental Factors, Lifestyle, Pathological Conditions and Pharmacological Agents." Cells, 2026;15(3):269.